title: Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise.
abstract: In attempt to elucidate whether the beta-adrenoceptor is involved in the control of atrial natriuretic peptide (ANP) secretion, plasma immunoreactive ANP level was measured at rest, in recumbent and upright positions, and during graded maximal ergocycle exercise in nine healthy male subjects (23 +/- 0.5 years of age) treated for 3 days with nonselective beta-blockers propranolol (150 mg/day) or pindolol (15 mg/day) or with placebo. The effects of beta-blockers, which differ by their hemodynamic actions at rest because of the intrinsic sympathomimetic activity of pindolol, were compared. Maximal O2 consumption (VO2max) during beta-blockade was not significantly different from the placebo value. Resting heart rate was not affected by pindolol treatment but was decreased with propranolol (-10 beats/min). Both beta-blockers caused a reduction in heart rate at all the exercise intensities. Mean blood pressure was not affected by beta-blockade at rest but was significantly reduced during exercise. During placebo treatment, plasma ANP increased in response to exercise intensities greater than 65% of VO2max. At 100% VO2max plasma ANP was nearly doubled (101.5 +/- 14 pg/ml) compared with the basal value in upright position (56.6 +/- 15 pg/ml). beta-Blockade caused a marked elevation in plasma ANP at all the levels of activity. Despite different hemodynamic responses to pindolol and propranolol, both beta-blockers produced similar increases in the basal level of plasma ANP. These rises were maintained in the course of exercise tests, and no significant difference was found between propranolol and pindolol. We conclude that beta-adrenoceptor mechanisms are not directly responsible for tonic and exercise-induced ANP secretion in humans.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Département de Physiologie, Faculté de Médecine de Créteil, Institut National de la Santé, France.
authors.forename: P
authors.initials: P
authors.lastname: Bouissou
authors.forename: F X
authors.initials: FX
authors.lastname: Galen
authors.forename: J P
authors.initials: JP
authors.lastname: Richalet
authors.forename: M
authors.initials: M
authors.lastname: Lartigue
authors.forename: F
authors.initials: F
authors.lastname: Devaux
authors.forename: C
authors.initials: C
authors.lastname: Dubray
authors.forename: G
authors.initials: G
authors.lastname: Atlan
mesh_terms: D000328:Adult; D009320:Atrial Natriuretic Factor / Q000097:blood*; D001794:Blood Pressure / Q000187:drug effects; D003971:Diastole / Q000187:drug effects; D004837:Epinephrine / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D005082:Physical Exertion; D010869:Pindolol / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D012016:Reference Values; D013599:Systole / Q000187:drug effects
chemical_list: D009320:Atrial Natriuretic Factor; D011433:Propranolol; D010869:Pindolol; D009638:Norepinephrine; D004837:Epinephrine